USD 1.68 Billion
Tumor Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation), By Treatment(Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), By Application(Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer), By Product Type(Generators, and Probes/electrodes (Radiofrequency Ablation Probes, Microwave Ablation Probes and Other Probes/Electrodes)), By End Use(Hospitals & Clinics, Cancer Care Centers, Other End Users), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A2494 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
95
|Figures:
76
Tumor Ablation Market Insights
Tumor Ablation Market size was valued at USD 1.34 Billion in 2023 and is poised to grow from USD 1.52 Billion in 2024 to USD 4.23 Billion by 2032, growing at a CAGR of 0.1362 during the forecast period (2025-2032).
Growing incidence of cancer around the world and rising preference for minimally invasive treatment procedures are expected to bolster the demand for tumor ablation over the coming years. Advancements in ablation technologies are also slated to create new opportunities for tumor ablation providers in the long run. Rising adoption of tumor ablation in outpatient facilities and growing popularity of combination therapies are also forecasted to bolster the sales of tumor ablation products in the future. Surging demand for novel cancer treatments and increasing investments in oncology research are also expected to present new business scope for tumor ablation companies going forward. Low to middle income countries are expected to be more opportune for tumor ablation providers owing to rapid rise in prevalence of cancers in these countries. On the contrary, high costs of tumor ablation equipment, competition from conventional cancer treatments, and limited awareness in developing regions are forecasted to impede tumor ablation market growth in the long run.
US Tumor Ablation Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Radiofrequency Tumor
Fastest Growth
Microwave
Growth Rate
13.5% CAGR
Global Tumor Ablation Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Tumor Ablation Market Segmental Analysis
The global tumor ablation market is segmented by technology, application, treatment, and region. Based on technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, High-intensity-focused Ultrasound (HIFU), and other ablation technologies. Based on treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Based on end users, the market is segmented into Hospitals & Clinics, Cancer Care Centers, and other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Analysis by Technology
Radiofrequency ablation is forecasted to account for a prominent tumor ablation market share over the coming years. High specificity and efficiency of this technology in the treatment of cancer is allowing it to hold sway over other technologies. The ability of radiofrequency ablation to treat multiple tumors concurrently is also expected to bolster its dominance over the coming years. High success rate of radiofrequency ablation technology in treating small tumors and its ability to treat cancer in the rapidly aging population are also expected to bolster the high share of this segment in the long run.
Meanwhile, the demand for microwave ablation technology is predicted to rise at an impressive pace across the study period and beyond. Faster treatment times as compared to radiofrequency ablation technology and better patient outcomes are helping this segment generate new opportunities in the global tumor ablation industry. Microwave ablation is mostly used as a standard treatment for liver tumors around the world. Minimal risk of complications and reduced hospital stays are also key benefits of microwave ablation helping tumor ablation companies create new revenue generation scope via this segment through 2031 and beyond.
Analysis by End User
Hospitals & clinics are estimated to account for the largest tumor ablation market share over the coming years. The growing number of cancer treatment procedures being performed in hospitals and the rising availability of novel tumor ablation treatment in the same are expected to aid the dominance of this segment going forward. Increasing investments in healthcare infrastructure development in developing countries is resulting in the creation of new hospitals and clinics, which are also expected to boost tumor ablation demand. Moreover, the high availability of multiple professionals and better pre and post procedure care are also helping this segment hold sway over others.
Meanwhile, the demand for tumor ablation is slated to rise at a robust pace in cancer care centers going forward. Increasing number of cancer care centers and rising number of treatment procedures performed in the same are creating new opportunities for tumor ablation providers via this segment. Rising preference of people for minimally invasive treatment procedures is also expected to boost sales of tumor ablation equipment in cancer care centers over the coming years. High emphasis on improving the quality of cancer care in these centers is also expected to promote the adoption of tumor ablation in this segment over the coming years.
Global Tumor Ablation Market By Technology (%)
To get detailed analysis on other segments, Request For Free Sample Report
Tumor Ablation Market Regional Insights
North America is estimated to secure the top spot when it comes to the global tumor ablation market forecast. The presence of a developed healthcare ecosystem, quick adoption of minimally invasive treatment technologies, and high investments in oncology R&D are expected to be key factors promoting the demand for tumor ablation in North America going forward. The United States is estimated to be the leading market for tumor ablation companies in this region owing to high incidence of different types of cancers and rising healthcare expenditure. Canada is also projected to create new opportunities for tumor ablation providers operation in this region.
Rapid increasing geriatric population and rising preference for minimally invasive treatments are expected to make the Asia Pacific region the fastest expanding market in the world. Growing investments in healthcare research and infrastructure development in countries such as India, China, and Japan are also expected to create a new business scope for tumor ablation providers in the long run. Supportive government initiatives to promote awareness regarding cancer and funding to promote proper cancer treatment are also slated to increase the sales of tumor ablation equipment in this region.
Global Tumor Ablation Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Tumor Ablation Market Dynamics
Tumor Ablation Market Drivers
Rising Incidence of Cancer
- Prevalence of cancer around the world is increasing at a rapid pace and this is projected to be a key factor driving up the demand for tumor ablation over the coming years. Tumor ablation is used for minimally invasive treatment of liver, lung, and kidney cancers and is especially popular among patients unfit for surgery.
High Preference for Minimally Invasive Treatments
- Rising awareness regarding the benefits of minimally invasive procedures among patients has increased their preference for the same. Reduced recovery times, lower complication rates, and cost-effectiveness are some key benefits of minimally invasive procedures. Since tumor ablation is a minimally invasive procedure, its demand is also expected to rise in the future.
Tumor Ablation Market Restraints
High Costs of Ablation Equipment
- Tumor ablation equipment is often expensive as it uses advanced technologies. These high costs result in the increased cost of treatment and also make these products inaccessible to healthcare establishments with limited spending potential. Hence, making high costs of equipment a key restraint for the tumor ablation market forecast.
Complications and Side Effects
- Even though tumor ablation is a minimally invasive procedure, the risks of infections and complications are still present just like any other treatment for cancer. Thermal damage to surrounding tissues, incomplete ablation, and post-procedural infections are some common issues that are expected to impede the adoption of tumor ablation over the coming years.
Request Free Customization of this report to help us to meet your business objectives.
Tumor Ablation Market Competitive Landscape
Tumor ablation providers around the world are estimated to focus on research to maximize their business potential and stay competitive. Developing new therapeutics for specific cancer indications will also be a preferred strategy for new as well as leading tumor ablation companies. Market players can also benefit from government support to take their oncology research capabilities to the next level. Use of advanced drug discovery and development techniques will also be popular among tumor ablation providers in the future.
Top Player’s Company Profiles in Tumor Ablation Market
- Medtronic plc (Ireland)
- Boston Scientific Corporation (US)
- Johnson & Johnson (Ethicon, Inc.) (US)
- AngioDynamics, Inc. (US)
- EDAP TMS S.A. (France)
- SonaCare Medical, LLC (US)
- Merit Medical Systems, Inc. (US)
- Misonix, Inc. (US)
- HealthTronics, Inc. (US)
- Galil Medical Ltd. (US)
- IceCure Medical Ltd. (Israel)
- Monteris Medical, Inc. (Canada)
- Hologic, Inc. (US)
- Symple Surgical Inc. (US)
- BVM Medical Limited (UK)
- Ablatherm (Esaote S.p.A.) (Italy)
- Bioventus LLC (US)
- CEVOTEC (Germany)
- Fujifilm Holdings Corporation (Japan)
- InSightec Ltd. (Israel)
- Philips Healthcare (Netherlands)
Tumor Ablation Market Recent Developments
- In July 2024, Techsomed Ltd., a leading medical software organization announced the launch of its new BioTrace software suite for its liver tumor ablation solutions. BioTraceIO Vision and BioTraceIO Precision were the ablation products that were launched last year and are operated by the newly launched software suite.
- In March 2024, Medtronic, a renowned healthcare technology company announced that it has received clearance from the United States Food and Drug Administration (FDA) for its novel bone tumor ablation offering. OsteoCool™ 2.0 is designed for the treatment of painful bone metastases and benign bone tumors.
- In September 2022, Stryker, a leading medical technology provider announced that it had received approval for its OptaBlate bone tumor ablation system. The United States FDA granted a 510(k) approval, which opened opportunities for Stryker to expand its ablation product portfolio.
Tumor Ablation Key Market Trends
-
Use of Imaging Guidance Technologies: Tumor ablation companies can focus on utilization of advanced imaging guidance technologies to improve the procedural accuracy and patient outcomes going forward. Real-time imaging using MRI, CT, and ultrasound technologies can help in reducing complications in tumor ablation procedures and increasing their success rates as well.
-
Adoption in Palliative Care: Tumor ablation providers can explore the use of their products for palliative care applications as emphasis on improving quality of life for patients rises around the world. This tumor ablation market trend is especially beneficial for late-stage cancer patients with no hope of complete treatment from the disease.
Tumor Ablation Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, growing incidence of cancer and rising demand for minimally invasive procedures around the world are slated to boost adoption of tumor ablation over the coming years. However, high costs of tumor ablation equipment and risk of side effects and complications are slated to be key constraints for market development going forward. High prevalence of cancer and presence of a large senescent population are helping North America spearhead the global tumor ablation market forecast. Use of imaging guidance technologies and exploring application scope in palliative care are expected to create new opportunities for tumor ablation providers going forward.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.48 Billion |
| Market size value in 2031 | USD 4.63 Billion |
| Growth Rate | al Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Tumor Ablation Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Tumor Ablation Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Tumor Ablation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Tumor Ablation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Tumor Ablation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Tumor Ablation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
